Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Hepatitis Monthly. 2011; 11 (4): 285-288
Dans Anglais | IMEMR | ID: emr-131144

Résumé

There are several studies on seroprevalence of hepatitis A virus [HAV] in adults in the Middle East. To determine seroprevalence of HAV among adult population in Fars province, southern Iran. In a cross-sectional study, we checked anti-HAV antibody [IgG] in subjected refereed to our health care centers to perform laboratory tests before getting determined. Some risk factors like level of education, type of residence, job, numbers of family members, and access to treated water were also evaluated in these participants. From 1050 subjects studied, 927 [88.2%] had ant-HAV antibody; 123 [11.8%] were antibody negative. Among subjects aged <20 years, the anti-HAV seroprevalence was the lowest [79.3%] followed by subjects aged 20-30 years [91.3%] and those >30 years [99%] [p= 0.01]. 85.1% of studied individuals in urban areas had anti-HAV IgG while 95.9% of subjects in rural regions were anti-HAV positive [p=0.001]. The seroprevalence of HAV antibody was significantly associated with number of family members [p=0.001]. HAV is highly prevalent in our region especially in rural areas. It is better to vaccinate the children for HAV by the time they receive HBV vaccine or when they are five years


Sujets)
Humains , Femelle , Mâle , Hépatite A/épidémiologie , Études transversales , Prévalence , Vaccins anti-hépatite A
SÉLECTION CITATIONS
Détails de la recherche